Navigation Links
Swine Flu Shots Safe for People With Weak Immune Systems: Experts
Date:9/18/2009

Another study outlines risks of catching H1N1 from various routes

FRIDAY, Sept. 18 (HealthDay News) -- The H1N1 swine flu vaccines approved this week by the U.S. Food and Drug Administration can be safely used by people with compromised immune systems, according to new recommendations from the American Academy of Allergy, Asthma & Immunology.

These would include people whose immune responses are weakened by medical treatments (such as for cancer or organ transplant) and those infected with HIV, the experts said.

Influenza vaccines can be made from live -- but modified and weakened -- virus, or they can be made from the harmless byproducts of the virus (so-called "killed" virus vaccines). According to the experts at the American Academy of Allergy, Asthma & Immunology (AAAAI), all of the injected H1N1 vaccines so far approved by the FDA are of the "killed" variety.

"There's never any harm with giving killed influenza vaccine" to immuno-compromised individuals, said Dr. Kenneth Bromberg, director of the Vaccine Research Center at The Brooklyn Hospital Center in New York City.

There is one vaccine out there that those with weakened immune systems should avoid: the nasal spray form of the seasonal ("regular") flu vaccine, FluMist.

FluMist is derived from live (but very weakened) virus, so it could pose a problem for people with poor immune systems. The recommendation to avoid FluMist extends to people living in close proximity to an immune-compromised person, such as family members, because they could pass on the live virus to that individual, the AAAAI said.

No such threat exists for average Americans with robust immune responses, the experts said.

One question for some people with compromised immune systems is whether the flu shot will actually help them, given their poor immune defenses.

People with so-called "primary" immune deficiency -- rare immune deficiencies inherited at birth -- can take the H1N1 vaccine, the academy said. "Although the antibody response may be poor or low [in these individuals], the cell-mediated response may be a helpful immune response to [fight] the virus," AAAAI President-elect Dr. Mark Ballow said in a news release issued Thursday.

But, depending on their level of immune cell function, certain HIV-infected individuals may not be able to mount enough of an immune response to make flu vaccination worthwhile, the experts said.

"The issue is whether the compromised immune response might result in insufficient protection, not whether the inactivated H1N1 or seasonal influenza vaccine is excessively harmful," said Dr. Paul Greenberger, president of AAAAI.

"The CDC (U.S. Centers for Disease Control and Prevention) notes that most HIV patients can receive the immunization, and from earlier studies with seasonal flu shots, [it appears] there may be a reduced response if the number of CD4+ lymphocytes is less than 100/mm3," Greenberger said. "Better responses occurred if patients had CD4+ lymphocyte counts of at least 400."

He added that "studies haven't been published yet of H1N1 vaccination in HIV patients."

In other swine flu news, a study published in the September issue of the journal Risk Analysis seeks to quantify the risk from various routes of transmission of the swine flu virus. Researchers from the University of California, Berkeley, and the University of Illinois used sophisticated modeling and pored over the available data on four key means of person-to-person H1N1 transmission.

They speculate that hand contact with a contaminated surface brings a 31 percent risk of actual infection; inhaling tiny particles laden with virus in a room brings a 17 percent likelihood of infection; close contact where coughs spray viral-laden droplets onto the eyes, nostrils or lips brings a 52 percent chance of infection. Inhaling relatively large particles carrying virus when three feet or nearer to an infected person carries only a 0.52 percent risk for infection, the research team said.

According to the researchers, the study strengthens current recommendations to cover the mouth when coughing and to disinfect commonly touched surfaces.

More information

There's more on H1N1 flu at the U.S. Centers for Disease Control and Prevention.



SOURCE: Paul Greenberger, M.D., president, American Academy of Allergy, Asthma & Immunology; Kenneth Bromberg, M.D., director, Vaccine Research Center, The Brooklyn Hospital Center, New York City; Sept. 17, 2009, news release, American Academy of Allergy, Asthma & Immunology; Sept. 16, 2009, news release, Society for Risk Analysis


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Swine Flu Loves a Crowd
2. FDA Approves 4 Swine Flu Vaccines
3. People With Swine Flu May Be Contagious Longer Than Thought
4. Small Businesses Urged to Prepare for Swine Flu
5. Swine Flu Trials Continue to Point to 1-Dose Vaccine
6. One Dose of Swine Flu Vaccine Offers Protection: Studies
7. H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk
8. Insite Security Hosts Webinar on Swine Flu Preparedness
9. Swine Flu Burrows Into Lungs: Study
10. Swine Flu Shots May Come Too Late to Stem Fall Outbreak: Study
11. With All Eyes On Swine Flu, Thousands of Parents Ask President Obama How Much Longer Until Autism Gets Similar Attention
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Swine Flu Shots Safe for People With Weak Immune Systems: Experts
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health ... Distinction, recognizing the organization as a top behavioral service provider in the country. ... clinical quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are measured ...
(Date:12/6/2016)... ... December 06, 2016 , ... Experimentation ... research and development, largely due to its potential for revolutionizing human disease treatment. ... and human induced pluripotent stem cells (hiPSCs). , Both platforms have distinct ...
(Date:12/6/2016)... ... December 06, 2016 , ... METTLER TOLEDO has ... knowledge resources, including white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, ... more than 9,000 documents, webinars and videos available online, visit the METTLER ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit ... EHS audit protocols to understand the scope of their EHS regulatory obligations and ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Nov. 29, 2016 Several leading Alzheimer,s ... Accera, Inc. at 11 a.m. EST on ... Conference on Clinical Trials for Alzheimer,s Disease (CTAD). The ... in Alzheimer,s disease and therapeutic targets that address deficient ... "Following the recent failure of another therapy targeting the ...
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. 5, ... Commercialization of Public Research (the Florida Institute) ... agreement SegAna, LLC, an Orlando ... Central Florida. The Florida Institute supports new company ... funding gaps for companies spinning out of Florida-based universities ...
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ Cartilage ... Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - Forecast ... USD 779.8 Million by 2021 from USD 414.6 Million in 2016, ... 2016 to 2021. Continue Reading ... ...
Breaking Medicine Technology: